Raytheon awarded $71 million in Navy contracts for missile systems
Quaker Chemical Corporation (NYSE:KWR), a leader in the production of specialty chemicals, announced today the retirement of Mr. Ramaswami Seshasayee from its Board of Directors, effective May 14, 2025. Mr. Seshasayee, who has been a part of the board since 2019, also served on the Audit and Compensation and Human Resources Committees.
The company stated that Mr. Seshasayee’s departure is voluntary and is not due to any disagreements with the company’s operations, policies, or practices. Following his retirement, the board will reduce its size from twelve to eleven directors.
This change in the board’s composition comes at a time when Quaker Chemical continues to navigate the complex market of petroleum and coal product manufacturing. The company, incorporated in Pennsylvania with headquarters in Conshohocken, PA, is known for its commitment to delivering high-performance chemical solutions across various industries. With annual revenues of $1.8 billion and a market capitalization of $1.9 billion, Quaker Chemical maintains a strong financial position, reflected in its GOOD financial health score according to InvestingPro analysis.
The information disclosed is based on a recent SEC filing by Quaker Chemical. The company’s common stock is listed on the New York Stock Exchange under the ticker symbol KWR. As per the filing, there are no further details provided regarding any new appointments to fill the vacated position or changes to committee assignments.
Investors and stakeholders of Quaker Chemical will be observing how the board’s reduced size will impact governance and strategic decisions moving forward. The company has not indicated any immediate plans for replacing Mr. Seshasayee or expanding the board to its previous number of directors. Notably, the company has maintained dividend payments for 53 consecutive years, demonstrating strong corporate governance and financial stability.
As is standard, Quaker Chemical has also included in its SEC filing an interactive data file as part of the current report, which is embedded within the Inline XBRL document for detailed financial analysis. The stock has experienced significant pressure, down 36% over the past six months, though InvestingPro analysis suggests the shares are currently undervalued. For deeper insights into Quaker Chemical’s valuation and comprehensive financial analysis, investors can access the detailed Pro Research Report, available exclusively to InvestingPro subscribers.
In other recent news, Quaker Chemical Corporation reported its Q1 2025 earnings, showing a slight miss on both earnings per share (EPS) and revenue forecasts. The company posted an EPS of $1.58, falling short of the expected $1.61, and revenue was $442.9 million, below the anticipated $455.58 million. Despite these misses, the company is implementing a $20 million cost-saving program and has improved its gross margins by 120 basis points from the previous quarter. Strategic acquisitions, including Dipsol Chemicals, are anticipated to drive growth, with Dipsol contributing approximately $80 million in sales and $15 million in EBITDA for 2024. Analysts from Seaport Research Partners and Jefferies have noted the company’s focus on cost management and strategic growth through acquisitions. Additionally, Quaker Chemical’s ongoing efforts to streamline operations and enhance its portfolio through acquisitions were highlighted as part of its strategy to maintain competitiveness in a challenging market environment. These recent developments reflect the company’s proactive approach to managing market conditions and positioning itself for future growth.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.